Bringing in health technology assessment and cost-effectiveness considerations at an early stage of drug development
Author:
Publisher
Wiley
Subject
Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology
Reference23 articles.
1. Improving the contribution of regulatory assessment reports to health technology assessments-a collaboration between the European medicines agency and the European network for health technology assessment;Berntgen;Value Health,2014
2. Economic evaluation alongside cancer trials: methodological and practical aspects;Bonsel;Eur. J. Cancer,1993
3. Progression-free survival: meaningful or simply measurable?;Booth;J. Clin. Oncol,2012
4. Pazopanib versus sunitinib in renal cancer;Casper;N. Engl. J. Med,2013
5. The ends justify the mean: outcome measures for estimating the value of new cancer therapies;Davies;Health Outcomes Res. Med,2012
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Health Inequality Impact of a New Cancer Therapy Given Treatment and Disease Characteristics;Value in Health;2024-02
2. Future directions in regulatory affairs;Frontiers in Medicine;2023-01-09
3. Some considerations on target estimands for health technology assessment;Statistics in Medicine;2022-11-17
4. Evidence of Chinese Herbal Medicine Use From an Economic Perspective: A Systematic Review of Pharmacoeconomics Studies Over Two Decades;Frontiers in Pharmacology;2022-05-05
5. Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis;Frontiers in Pharmacology;2021-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3